Search
for
Sort by
Research 331–360 of 1000+
- Comparative Evaluation of Superficial Cryotherapy vs Intralesional Triamcinolone in Alopecia Areata at a Tertiary Care Center: A Dermoscopic and Clinical Study in Middle-aged Adults
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- To evaluate the role of interleukin-6 in alopecia areata
- Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling
- Role of microneedling in treatment of alopecia areata
- Estimation of health utility values for alopecia areata
- How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- The Ratio of Typical Clubbing in Pulled-Out Hairs as a Useful Marker in Predicting the Course of Alopecia Areata
- Combination therapy of alopecia areata using cyclosporine and low-dose corticosteroid: A long-term follow-up study
- Serum 25-Hydroxy Vitamin D Level in Patients with Alopecia Areata and Its Relationship with Severity of the Disease
- Histopathologic prognostic factors for alopecia areata treated by intralesional corticosteroid
- Treatment of Alopecia Areata With Tofacitinib
- Serum level of interleukin-15 in active alopecia areata patients and its relation to age, sex, and disease severity
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Association of vitamin D level with alopecia areata
- Oxidative Stress in Alopecia Areata and its Association with Disease Severity, Treatment and Autoimmunity
- Stressful lie events in alopecia areata patients: A case control study
- Cardiovascular risk factors and co-morbidities in patients with Alopecia Areata: A case-control study
- Association of Serum IL-17A and IL-23 Levels With Alopecia Areata: A Cross-Sectional Comparative Study
- Patient Validation of Estimation of Health Utility Values in Alopecia Areata
- Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alopecia areata: a randomized controlled study
- The evaluation of IL-4 intron 3 VNTR and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with Alopecia Areata: a case-control study
- Trichoscopy of alopecia areata: An update
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Tofacitinib therapy for children with severe alopecia areata
- ‘Follicular Swiss cheese’ pattern - another histopathologic clue to alopecia areata